He has patents pending with FlyteHealth and has served on the board of directors for FlyteHealth, Jamieson Wellness and ERX Pharmaceuticals
When Zepbound is covered, prior authorization is usually required, and the patient may need to meet clinical requirements such as a BMI of 30 or more or a BMI of 27 or more with a comorbid condition like hypertension or Type 2 diabetes, and documented weight management efforts like a low-calorie diet and increased physical activity
No crash
The research-supported minimum is 1.2 grams per kilogram of body weight per day
Results Clinicopathological Characteristics of Malignant Peripheral Nerve Sheath Tumors Patient characteristics of 122 malignant peripheral nerve sheath tumors are presented in Table 1
Toda T, Hsu JY, Linker SB, Hu L, Schafer ST, Mertens J, et al